Magnetic Resonance Imaging: Clinical Trials

7 trials for Magnetic Resonance Imaging, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 terminated, 1 unknown. 7 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 47Completed 5, Terminated 1, Unknown 1

Follow Magnetic Resonance Imaging: new trials by email Literature Review of Magnetic Resonance Imaging trials Research Report on Magnetic Resonance Imaging

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Gadovist 75% Standard Dose to Dotarem at Full Standard Dose
Gadoterate (Dotarem/Clariscan), Gadobutrol (Gadavist/Gadovist, BAY86-4875) - Magnetic Resonance Imaging
Phase 4CompletedBayer1572018-11-142021-06-14
Effects of Nonsteroidal Anti-inflammatory Drug (NSAID) on Inflammatory Lesion of Axial Spondyloarthritis
Celecoxib - Spondylarthropathies, Magnetic Resonance Imaging
Phase 4CompletedArmed Forces Capital Hospital, Republic of Korea122018-06-012018-06-06
Effect of Midazolam and Dexmedetomidine on Heart Function - A Randomized MRI-based Study.
Midazolam, Dexmedetomidine - Cardiac Function, Sedation
Phase 4CompletedMasaryk Hospital Krajská zdravotní a.s.302018-01-012020-08-27
DOTAREM Pharmacokinetics and Safety Study in Pediatric Subjects Aged < 2 Years
DOTAREM - Magnetic Resonance Imaging
Phase 4CompletedGuerbet512015-03-012017-03-09
Cardiac MRI After Pacemaker Replacement
cardiac MRI group - Bradycardia, Cardiac Pacemaker
Phase 4TerminatedDr. Dirk Bastian232014-07-012021-01-12
Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosis
18F-FCH, Magnevist - Breast Cancer Diagnosis, Positron Emission Tomography
Phase 4UnknownNational Taiwan University Hospital802012-09-012016-02-04
Silent Cerebrovascular Lesion and Cognitive Decline Prevention by Cholesterol Lowering in Elderly AF Patients
Atorvastatin, ezetimibe - Atrial Fibrillation, Neuropsychology
Phase 4CompletedRadboud University Medical Center352005-05-012007-03-20

Narrower conditions

Atrial Fibrillation (1)  ·  Bradycardia (1)  ·  Breast Neoplasms (1)  ·  Cerebrovascular Disorders (1)  ·  Inflammation (1)  ·  Spondylarthropathies (1)

Broader conditions

Arrhythmias, Cardiac (2)  ·  Cardiovascular Diseases (2)  ·  Heart Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Arthritis (1)  ·  Bone Diseases (1)  ·  Brain Diseases (1)  ·  Breast Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Joint Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Nervous System Diseases (1)

Interventions

gadoterate meglumine (2)  ·  Atorvastatin (1)  ·  Celecoxib (1)  ·  Dexmedetomidine (1)  ·  Ezetimibe (1)  ·  Gadolinium DTPA (1)  ·  Midazolam (1)  ·  ferumoxtran-10 (1)  ·  fluorocholine (1)  ·  gadobutrol (1)  ·  gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate (1)

Sponsors

Armed Forces Capital Hospital, Republic of Korea (1)  ·  Bayer (1)  ·  Dr. Dirk Bastian (1)  ·  Guerbet (1)  ·  Masaryk Hospital Krajská zdravotní a.s. (1)  ·  National Taiwan University Hospital (1)  ·  Radboud University Medical Center (1)

Countries

France (2)  ·  Germany (2)  ·  South Korea (2)  ·  Austria (1)  ·  Czechia (1)  ·  Hungary (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Switzerland (1)  ·  Taiwan (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Dirk Bastian, MD (1)  ·  Gheorghe AM Pop, MD PhD (1)  ·  Jane Wang, PhD (1)  ·  Janet Kuilenburg, MD (1)  ·  Nedal Omran, M.D (1)

Results publications

PMID 23809138, PMID 34133205

NIH funding

2018 (1)